Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This is a minor platform update and does not alter study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-28T14:42:59.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.0 tag. This signals a minor update to the page rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-06-30T01:00:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The recruitment status now indicates the study is not enrolling participants, and new navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study). Additionally, the Intervention/Treatment heading formatting was adjusted and the site revision note updated to Revision: v3.6.0 (replacing v3.5.5).
    Difference
    0.3%
    Check dated 2026-06-15T18:27:33.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a minor administrative update to the page. This change does not affect the study content or displayed data.
    Difference
    0.0%
    Check dated 2026-06-08T15:18:03.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The study record now shows a new document revision (Revision: v3.5.4) and indicates a Redacted CSR Synopsis, with the prior revision (v3.5.3) removed.
    Difference
    0.2%
    Check dated 2026-05-18T03:31:04.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    This updates the displayed interface/version identifier on the page (revision v3.5.0 → v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:18:44.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.